Lipitor

(Thinkstock)

New Drugs Shown To Dramatically Reduce Cholesterol

WASHINGTON (AP) — A new class of experimental medicines have shown to dramatically lower cholesterol, raising hopes of a fresh option for people who can’t tolerate or don’t get enough help statin drugs, like Lipitor, […]

03/30/2014

WebRecall

Ranbaxy Recalls Generic Version Of Lipitor

Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once led U.S. regulators to bar imports of the Indian company’s medicines.

CBS4–11/26/2012

Lipitor(atorvastain calcium) tablets made by Pfizer and distributed by Parke-Davis are seen November 30, 2011 in Washington, DC. Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on November 30, 2011, opening the path to generic competitors for America's most popular medication. Lipitor came on the market in 1997, and has raked in some $100 billion for Pfizer even in a crowded market that includes various other cholesterol-lowering statins, many of which have already gone generic. In the United States, anti-cholesterol drugs account for 255 million prescriptions a year, and about nine million people are taking Lipitor. AFP Photo/Paul J. Richards (Photo: PAUL J. RICHARDS/AFP/Getty Images)

Risk Of Glass Particles In Generic Lipitor Prompts FDA Recall

Ranbaxy Pharmaceuticals Inc. is recalling more than 40 lots of atorvastatin pills — the generic version of the popular statin Lipitor — over possible glass contamination.

CBS4–11/23/2012

pills

Generic Versions Of Lipitor On The Way

Cheaper generic versions of the popular cholesterol lowering drug Lipitor will soon be hitting the market. Pfizer Inc.’s patent protection for Lipitor expires on Wednesday.

CBS4–11/30/2011

Follow

Get every new post delivered to your Inbox.

Join 1,602 other followers